Investigators assessed whether intravesical BCG is necessary for patients with high-grade T1 nonmuscle-invasive bladder cancer who have unremarkable histology on the second transurethral resection.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback